FDA Import Refusal 310-9103849-2/1/1 — Celgene Cellular Therapeutics

Celgene Cellular Therapeutics — FEI 3000206490

The FDA refused shipment 310-9103849-2/1/1 from Celgene Cellular Therapeutics (United States) on Jul 18, 2003. The refused product falls under Drugs and Biologics — THALIDOMIDE (SEDATIVE). Cited charge: 179 This firm has 3 other import refusals on record.

Refusal details

Date
Jul 18, 2003
Country
United States
Product Category
Drugs and Biologics
Product Code
65VIY40 THALIDOMIDE (SEDATIVE)
Charges
179

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.